Recent Finacing
Recent Raise
Oncologie, based in Boston and Shanghai, uses proprietary biomarkers to develop clinical‑stage immuno‑oncology therapies (PS‑targeting mAb, TLR9 activator, VEGF antibody) for combination and parallel U.S.–China trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
